This weekend saw a variety of updated data presentations roll out from ASCO GI – think of the wide range of tumour types encompassing gastric, colorectal, liver, biliary, and pancreatic cancers.

What stood out from the crowd and why?

What are the threads and connections which might hold things together?

And why does KRAS keep cropping up in unusual and unexpected places?

To learn more from our oncology analysis and get a heads up on the latest insights and analysis pertaining to cancer conference coverage, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by